In July 2019, Pharmaceutical company Reckitt Benckiser Group settled a federal lawsuit that they fraudulently marketed their addiction treatment drug Suboxone. They’ll pay a huge fine but why doesn’t this settlement actually result in justice?
An article in the New York Times from April 29th, 2019 shone a light on the opioid addiction crisis and highlighted a phenomenon we are very glad to see. Medical doctors, usually pain pill advocates, are turning their backs on pharmaceutical opioids and are making a stand against the very companies that manufacture them.
There’s something special and even a little energizing when the bad guy finally gets caught. When the underdog hero somehow manages to win against insurmountable odds.
In a nation that struggles with a drug addiction epidemic, our society rapidly seeks solutions and methodology for reducing the drug problem.
Many of us silently cheer when we hear about a mega-corporation losing a lawsuit against an underdog. This particular aspect of human nature is evidenced in Hollywood films, music, books, pop culture, and bedtime stories.
As our great nation continues to struggle with a sweeping drug problem, the American people have attempted to create new ways and means of addressing that problem. Not all such approaches have been successful or sensible.
I was surfing through U.S. News the other day when I came across a news story that really caught my eye. U.S. News posted an article titled, “Pennsylvania Supreme Court Rules Pregnant Women Abusing Drugs is Not Child Abuse.”Having worked in addiction treatment most of my adult life, this story hit close to home for me.
There was a recent article in the Washington Post which caught my eye. The report was about county prosecutor candidates competing for votes in Virginia. The article discussed the layered nuances of criminality and drug use.
All across the nation, our country has experienced increasing drug problems and addiction issues. But even though the entire nation as a whole has experienced growing drug problems and issues, the entire nation has not experienced this crisis equally.
While U.S. politicians have historically left pharmaceutical organizations alone and have even, in fact, flowed them power, one U.S. Senator is making waves by doing the exact opposite.